Increase Access To MedTech: AdvaMed’s Priorities For The 118th Congress
AdvaMed’s Medical Innovation Agenda for the 118th Congress emphasizes increased access to medical devices, from reimbursement for breakthrough devices to boosting America’s start-ups to closing the care disparities for underserved communities.
You may also be interested in...
Stack Of New And Revised EU MDR and IVDR Guidances In The Pipeline
The EU has published a lengthy list of new guidances to be drafted as well as existing guidance documents that need updating in the context of its MDR and IVD medtech regulations, including covering the interpretation of the Medical Device Regulation wording on “significant changes.”
FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics
The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal.
What Can Tech Companies Teach Us About Clinical Trials?
Collaboration between tech companies and medical researchers may be the answer to modernizing clinical trials.